Features

Santiago Cornejo – Biogenesis Bago

Going the distance to ensure livestock safety

It helps to go the extra mile. Or, more precisely, the extra 8,000 miles.

That’s roughly the distance as the plane flies between Buenos Aires in Argentina and Riyadh in Saudi Arabia. The Middle East seemingly prime territory for the kind of livestock medication Biogenesis Bago produces and distributes throughout South America and beyond, it was only appropriate that one of its legal bosses visit prospective partners there last summer.

Some deals, such as a 50-50 partnership with the Saudi Arabian veterinary services company MAS, you just don’t want to do online.

“They need to see you and talk with you one-on-one,” Santiago Cornejo, the legal diretor of Biogenesis Bago, tells Vanguard in April.

Santiago Cornejo | Legal Director | Biogenesis Bago

Santiago Cornejo | Legal Director | Biogenesis Bago

“They’re not comfortable just signing over their money. By going there, we showed we were serious about closing this deal and entering a long-term relationship and that we’d provide the technology and expertise to make it work. They had to know we wouldn’t just make the deal and leave.”

Language and cultural barriers overcome, grounds will soon break for Saudi Arabia’s first animal vaccine facility—a $60 million endeavor—with commercial production expected to commence by late 2024 or early 2025. Crown Prince Mohamed bin Salman intent on diversifying the Saudi economy beyond oil and energy, this fits his agenda while opening the door to Biogenesis Bago’s Middle East expansion.

Meanwhile Cornejo says he can call his legal counterparts in Saudi Arabia and chat jovially. It’s all about earning one’s trust and respect.

And there’s certainly a need, he explains, for Biogenesis Bago’s vaccines to safeguard against foot-and-mouth disease transmissible in cattle, goats and sheep. The Saudi kingdom also protective of its meat industry, it’s been known to suspend importation of beef and other animal products.

From Mideast to Asia

Just a couple hours after sealing the deal in Riyadh, Cornejo was on the phone with an Asian company negotiating a similar project. Visa and quarantine protocols didn’t allow him to travel there, so he had to connect virtually. For the Far East, that means a different tact.

“They’re very tough negotiators,” he says. “The Saudis have more in common with Latin America—they like soccer and horses. You also have to show the other part they’re entering a partnership that represents a win-win situation.”

Santiago Cornejo | Legal Director | Biogenesis Bago

As a result of those negotiations, which carried on for nine months, Biogenesis Bago can expand its Asian footprint, which also includes the construction of the world’s largest animal vaccine plant in China—another successful joint venture. Cornejo notes there’s a correlation between the health of animals and people, with diseases sometimes transmitted from the former to the latter.

“We are increasingly focused on international business,” he says. “We are growing by 15 percent revenue per year and are among the best companies in animal health.”

Not that he doesn’t have enough to do on this side of the world where Biogenesis Bago’s Argentina headquarters are augmented by subsidiaries in Uruguay, Paraguay, Bolivia, Colombia, Brazil and Mexico.

Going beyond vaccines

Though long noted for its large livestock vaccines that are mainstays on Latin American farms and ranches, Biogenesis Bago is diversifying into other animal health solutions.

With Cornejo’s help, the company expects to be among the world’s top producers of reproductive medicines and vitamins. It’s bought a diagnosis lab and a Brazilian license to manufacture swine medication, initiatives that will help the company’s goals in Asia where pork production is fundamental to the economy.

Santiago Cornejo | Legal Director | Biogenesis Bago

The company also has foot-and-mouth disease related services, such as the FMD Antigen and Vaccine Bank that supports countries, such as United States, on preparedness for a possible outbreak. The company is also expanding in the companion-animal, or pet, market, where there is still room to grow.

That leaves Cornejo with a to-do list that includes commercial contracting, intellectual property protection, regulatory compliance and management of outside counsel in every country where Biogenesis Bago has a presence. He oversees four other lawyers, helped create a code of ethics and sits on that committee.

He says it’s been a whirlwind five years since joining the legal team, but he came to the job well prepared.

An easy choice

A Universidad Austral, Buenos Aires law graduate, Cornejo earned a master’s degree in banking, corporate and finance law in 2014 from Fordham University and honed his skills in private practice. He and his wife, who now have three young children, then moved to New York.

“I love New York,” he says. “I lived on the Upper West Side my first year and the Upper East Side my second year. New York’s the greatest city. You cannot get bored there.”

Santiago Cornejo | Legal Director | Biogenesis Bago

Home being Argentina, Cornejo and his wife returned in 2015 with him taking a position as a senior associate with the Buenos Aires office of Allende & Brea, which is noted for technology industry expertise. In house, however, was where he thought he could make his biggest impact, and it came down to a choice of Biogenesis Bago and a French oil company.

For Cornejo, the choice was easy—he relishes the opportunity to weigh in on such an essential industry. Foot-and-mouth disease is highly infectious among cloven-hoofed animals and countries deemed to be at low risk have the greatest access to beef exports. Argentinian beef prized worldwide, the integrity of its cattle herds is an economic necessity.

And a health necessity, Cornejo is quick to add.

“We support one health,” he says. “By keeping animals healthy, we’re keeping humans healthy. And I want to continue accompanying the growth of this company. I don’t see a ceiling.”

View this feature in the Vanguard Spring IV 2022 Edition here.

Published on: May 25, 2022

regions:

categories: ,

Showcase your feature on your website with a custom “As Featured in Vanguard” badge that links directly to your article!

Copy and paste this script into your page coding (ideally right before the closing tag) where you want to display our review banner.

Testimonials

I was honored to be the subject of an article. I enjoy reading Vanguard articles and seeing how other attorneys got to their positions and see their jobs. It's also interesting to see how different law firms partner with the subjects of the articles.
– Henry Marquard, in-house counsel, Stanley Consultants Inc.
The piece highlighting my company, Bob Baker Enterprises, Inc., came out fabulous. Our company is in the new and used car sales and service industry. Everyone was great to work with and extremely professional. They produced a high-quality product and have provided expert assistance and guidance post-production of the article.
– Wade Poulson, General Counsel, Bob Baker Enterprises Inc.
It was a great honor to be featured in Vanguard Law. Working with every member of the team, from the initial interview with Erin Clark, through production with Victor Martins, writing the article with Taryn Plumb and creating the final content with Dave Gushee, was a true pleasure. Everyone was very professional, enthusiastic and supportive, and their creative approach and positive attitude clearly came through in the final product.
– Kevin C. Rakowski, Senior Vice President, Deputy General Counsel, Compliance with Radian Group Inc.
As promised in advance, my feature in Vanguard has increased my visibility within the profession and prompted more than a few people I have not communicated with recently to reconnect. One of the Italian law firms I have used in the past is now in the process of interviewing me for an article on their website and tweeting out the feature story. Activity and the number of people connecting with me on LinkedIn has soared, which is great. The Vanguard writers and editorial staff were great to work with—highly professional and made the effort to make the experience both fun and rewarding (they were also respectful of the time pressures and demands all lawyers face). I was very pleased with the experience and the final outcome. Needless to say, I have been very pleased. All in all working with Vanguard has been a very positive experience which generated good publicity for both Shawcor and myself. My sincere thanks.
– Tim Hutzul, General Counsel, ShawCor Ltd.

LATEST EDITION

Spring III 2023

READ NOW

GET VANGUARD IN YOUR INBOX.

  • * We’ll never share your email or info with anyone.
  • This field is for validation purposes and should be left unchanged.